More on ZLAB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1,400.0% Growth)
- Ratings (8.6 Score)
- Holders

Upcoming Events

- Earnings (8/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Zai Lab Limited (NQ:ZLAB)
Delayed: 18.18 +0.30 (1.68%)
Prev. Close $17.88  
Open$18.45 
52 Wk High$ 
52 Wk Low$ 
Day High$19.11 
Day Low$18.15 
P/E N/A  
EPS$ 
Volume978,130 

Friends, Peers and Foes (?): 1ZLB, S1GE34, RMD, ACLX, AGIO (more...)

Jun 17, 2026 04:06 PM Form 8-K Zai Lab Ltd For: Jun 17
Jun 16, 2026 07:01 AM ZAI LAB wins EMA orphan drug status for lung cancer treatment
Jun 16, 2026 07:00 AM Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas
Jun 11, 2026 07:02 PM Form SCHEDULE 13G Zai Lab Ltd Filed by: TCG Crossover GP II, LLC
Jun 9, 2026 03:54 AM Zai Lab wins China approval for cervical cancer drug TIVDAK
Jun 8, 2026 08:34 PM Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer
May 21, 2026 06:39 PM Zai Lab removes president and COO Josh Smiley from leadership team
May 21, 2026 06:09 PM Zai Lab Announces Changes to Senior Leadership Team
May 21, 2026 05:19 PM Form 8-K Zai Lab Ltd For: May 18
May 20, 2026 07:37 AM Zai Lab (ZLAB) PT Lowered to $27 at JPMorgan
View All Articles

Entities mentioned with ZLAB

View All Entities